VCs and founders backing AI startups are gaming annual recurring revenue figures to inflate growth narratives, according to TechCrunch reporting. The practice involves counting projected or annualized revenue from pilots, trials, and non-binding commitments as if they were locked-in recurring contracts.
The tactic inflates ARR claims significantly. A startup running a three-month customer pilot might annualize that revenue run-rate to $4 million ARR, even if the customer never converts to a paid contract. Another common move: counting tentative enterprise deals as confirmed ARR before contracts close.
Investors backing these companies know what's happening. VCs are aware founders present generous ARR figures to press and in pitch decks. The practice has become endemic in AI startup fundraising, where investor appetite remains high but due diligence standards have loosened. Money chases promises, not proven unit economics.
The reality gap matters. When these startups raise Series B or C rounds, the inflated ARR gets baked into valuations. A startup claiming $10 million ARR but actually generating $2 million repeatable revenue trades at a multiple based on fiction. This inflates entry prices for subsequent investors and creates unsustainable valuation cycles.
Traditional SaaS founders faced accountability for ARR claims through customer references and verifiable contracts. AI startups have exploited the technology's novelty and the hype cycle to loosen that rigor. Founders argue their pilots represent genuine customer intent. VCs argue early-stage AI companies don't fit old metrics.
But the math breaks down eventually. When portfolio companies miss projections at Series C or D, rounds compress valuations or fail to close. The inflated metrics become liabilities rather than assets.
Some VCs have started pushing back, demanding clearer revenue classifications. They distinguish between "contracted ARR," "trailing ARR," and